At Heart Rhythm 2019, we spoke with Dr Jose Merino (Director, Arrhythmia and Robotic Electrophysiology Unit, Hospital General Universitario La Paz, Madrid, Spain) about the current unmet needs in atrial fibrillation ablation, and the potential causes and ways to minimise the risk of oesophageal damage during atrial fibrillation ablation.
Speaker’s Disclosures: Jose Merino has received speaker’s, educational and research services fees from Abbott, Bayer, Biotronik, Boston Scientific, Cardiome, Daiichi, Medtronic, Microport and Sanofi.
Questions:
1. What are the current unmet needs in atrial fibrillation ablation? (0:06)
2. What are the potential causes for oesophageal damage during ablation? (1:03)
3. How can these risks be minimised in routine practice? (2:27)
4. What are your highlights from Heart Rhythm 2019? (3:45)
touchCARDIO.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via free-to-access content in multimedia formats.
